Literature DB >> 11179590

Pattern of childhood cancer mortality in Mexico.

F I Abdullaev1, R Rivera-Luna, V Roitenburd-Belacortu, J Espinosa-Aguirre.   

Abstract

Public and governmental concern regarding increasing cancer mortality trends in children in Mexico led us to investigate the current situation of childhood cancer in this country, as well as to discuss the reasons for which no decline in total and childhood cancer mortality has been documented during the past decades. The data used for analysis of total cancer mortality and study of the trends in mortality of specific childhood cancer in Mexico were retrieved from official Mexican Cancer Mortality Statistics for the period of 1955-1995, as well as from the latest official death records of the Mexican National Institute of Statistics, Geography and Informatics. Actual mortality rates from all sites of cancer in Mexico show a tendency to increase in adults and in children over the last decades. The mortality rate due to all malignant neoplasms in the Mexican population increased significantly, from 28.1 per 100,000 inhabitants in 1955 to 52.6 per 100,000 inhabitants in 1995, whereas the rate of total mortality tended to decrease. The death rate among Mexican children under 15 years of age from all malignant neoplasms increased from 1980-1995 by 20.3%. Although these findings offer some support for the suggestion that socioeconomic factors and delayed diagnosis and treatment may be the major contributors to childhood cancer death rates in Mexico, other explanations cannot be excluded. Further and more detailed research into the nature of the influence of environmental exposures, geographical distribution-including rural vs. city life-and purely biological factors concerned with the cancer situation is warranted. Predictions indicate that the increase of both total and childhood cancer mortality will continue. The pattern in the epidemiology of childhood diseases is changing in view of better national health measures to control infectious diseases, diarrheas, and neonatal problems. All these measures would lead to an increase in the incidence of childhood cancer in children who previously died of other causes. Therefore, improved registry, early diagnosis, better knowledge of the epidemiologic pattern of childhood cancer, appropriate treatment, and greater resources are necessary to solve this emerging health problem in Mexico.

Entities:  

Mesh:

Year:  2000        PMID: 11179590     DOI: 10.1016/s0188-4409(00)00094-1

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  11 in total

1.  Addressing regional disparities in pediatric oncology: Results of a collaborative initiative across the Mexican-North American border.

Authors:  Paula Aristizabal; Spencer Fuller; Rebeca Rivera-Gomez; Mario Ornelas; Laura Nuno; Carlos Rodriguez-Galindo; Raul Ribeiro; William Roberts
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

2.  A study on the toxic effects of Doxorubicin on the histology of certain organs.

Authors:  P Shivakumar; M Usha Rani; A Gopala Reddy; Y Anjaneyulu
Journal:  Toxicol Int       Date:  2012-09

3.  Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in Rats.

Authors:  Maysa Ahmed Mobasher; Hala Galal El-Tantawi; Karim Samy El-Said
Journal:  Rep Biochem Mol Biol       Date:  2020-04

4.  Impact of the Mexican government's system of social protection for health, or Seguro Popular, on pediatric oncology outcomes.

Authors:  Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2012-10-12       Impact factor: 3.167

5.  Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood.

Authors:  Julia E Heck; Andrew S Park; Jiaheng Qiu; Myles Cockburn; Beate Ritz
Journal:  Int J Hyg Environ Health       Date:  2013-12-25       Impact factor: 5.840

6.  In vitro cytotoxicity study of agave americana, strychnos nuxvomica and areca catechu extracts using mcf-7 cell line.

Authors:  Chetan C Anajwala; Rajesh M Patel; Sanjay L Dakhara; Jitesh K Jariwala
Journal:  J Adv Pharm Technol Res       Date:  2010-04

7.  Indigofera suffruticosa: an alternative anticancer therapy.

Authors:  Jeymesson Raphael Cardoso Vieira; Ivone Antônia de Souza; Silene Carneiro do Nascimento; Sônia Pereira Leite
Journal:  Evid Based Complement Alternat Med       Date:  2007-09       Impact factor: 2.629

8.  Mangiferin induces cell death against rhabdomyosarcoma through sustained oxidative stress.

Authors:  Vishwanadha Vijaya Padma; Palanisamy Kalaiselvi; Rangasamy Yuvaraj; M Rabeeth
Journal:  Integr Med Res       Date:  2014-10-02

9.  Risk of Childhood Cancer by Maternal Birthplace: A Test of the Hispanic Paradox.

Authors:  Julia E Heck; Andrew S Park; Zuelma A Contreras; Tom B Davidson; Katherine J Hoggatt; Myles Cockburn; Beate Ritz
Journal:  JAMA Pediatr       Date:  2016-06-01       Impact factor: 26.796

10.  Improving Pediatric Cancer Care Disparities Across the United States-Mexico Border: Lessons Learned from a Transcultural Partnership between San Diego and Tijuana.

Authors:  Paula Aristizabal; Spencer Fuller; Rebeca Rivera; David Beyda; Raul C Ribeiro; William Roberts
Journal:  Front Public Health       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.